Corline Biomedical AB logo

Corline Biomedical AB (CLBIO)

Market Open
11 Dec, 09:54
XSTO XSTO
kr
16. 95
-0.35
-2.02%
kr
203.76M Market Cap
- P/E Ratio
0% Div Yield
5,429 Volume
- Eps
kr 17.3
Previous Close
Day Range
16.95 17.4
Year Range
7.66 27.2
Want to track CLBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
Name Time Cons. EPS Eps
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
16 Feb 2026 (In 2 months)
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
5 Nov 2025
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
26 Aug 2025
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
28 Apr 2025
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
12 Feb 2025
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
7 Nov 2024
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
23 Aug 2024
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
15 May 2024
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
30 Apr 2024
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
14 Feb 2024
-
-
Corline Biomedical AB logo
CLBIO Corline Biomedical AB
10 Nov 2023
-
0.01

CLBIO Earnings Reports FAQ

What is the earnings per share (EPS) for CLBIO?

EPS data for CLBIO is currently not available, as Corline Biomedical AB has not reported recent earnings.

What is the company's earnings growth rate?

Corline Biomedical AB has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-16, based on the CLBIO's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Corline Biomedical AB are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for CLBIO at this time, as Corline Biomedical AB has no recent EPS data to calculate it.